AVIPERO Revenue
Biotechnology Research • 
Wilmington, Delaware, United States • 1-10 Employees
$
AVIPERO revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Key Contact at AVIPERO
John N Bonfiglio
Member Board Of Directors
Company overview
| Headquarters | Wilmington, Delaware, United States |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Keywords | Copd, Arthritis, Drug Development, Cancer, Parkinson'S Disease, Tissue Repair, Allosteric Modulator, Integrin, Regenrative Medicine, Metastatic Breast Cancer |
| Founded | 2023 |
| Employees | 1-10 |
| Socials |
About AVIPERO
AVIPERO is developing unique allosteric modulators of integrins for Tissue repair and age-related diseases.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Director
Funding Data
AVIPERO has never raised funding before.
United Kingdom
France
Spain
Frequently asked questions
AVIPERO is located in Wilmington, Delaware, US.
AVIPERO generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.
AVIPERO has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
AVIPERO was founded in 2023, making it 3 years old. The company has established itself as a significant player in its industry over this time.
AVIPERO has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
